Save the date

ICS22-PMI - banner

Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Preview

Please note: Once you watch the video, data will be transmitted to Youtube/Google. For more information, see Google Privacy.

Cluster news

[EN]

Award for research on anti-inflammatory peptides

A team from the Cluster of Excellence PMI at the Research Center Borstel has been awarded the Leibniz Drug of the Year 2022.

 
[EN]

New research network on heredity in heart attacks

Prof. Jeanette Erdmann and Prof. Inke König from the Cluster of Excellence PMI receive funding from the German Research Foundation for identifying new rare risk variants and genes for atherosclerosis and myocardial infarction.

 
[EN]

Immune responses in chronic inflammatory bowel diseases

A research team from the Cluster of Excellence “Precision Medicine in Chronic Inflammation” has discovered a new population of immune cells that is highly abundant in Crohn’s disease patients.

 
Jaw bones of a human

Genetic legacy of earlier epidemics

Why is the Cluster of Excellence "Precision Medicine in Chronic Inflammation" researching ancient DNA? In unizeit, Prof. Ben Kraus-Kyora explains how his findings help to improve our understanding today’s inflammatory diseases.